Researchers Are Hatching a Low-Cost Covid-19 Vaccine – The New York Times

In contrast, the brand-new vaccine can be mass-produced in chicken eggs– the same eggs that produce billions of influenza vaccines every year in factories around the world.If NVD-HXP-S shows safe and reliable, flu vaccine makers might potentially produce well over a billion doses of it a year.” The share of the vaccines theyve gotten so far is terrible,” Dr. McLellan said.To that end, the University of Texas set up a licensing plan for HexaPro that enables companies and labs in 80 low- and middle-income nations to utilize the protein in their vaccines without paying royalties.Meanwhile, Dr. Innes and his colleagues at PATH were looking for a method to increase the production of Covid-19 vaccines. They desired a vaccine that less wealthy nations could make on their own.With a little assistance from eggsThe very first wave of authorized Covid-19 vaccines need specialized, pricey ingredients to make. That way, the same factories that make flu shots might make Covid-19 shots as well.In New York, a team of researchers at the Icahn School of Medicine at Mount Sinai knew how to make just such a vaccine, using a bird virus called Newcastle disease infection that is harmless in humans.For years, researchers had been exploring with Newcastle disease virus to develop vaccines for a variety of illness. The Mount Sinai team has actually also licensed the vaccine to the Mexican vaccine maker Avi-Mex as an intranasal spray.

In contrast, the new vaccine can be mass-produced in chicken eggs– the same eggs that produce billions of influenza vaccines every year in factories around the world.If NVD-HXP-S proves reliable and safe, flu vaccine manufacturers might potentially produce well over a billion doses of it a year. McLellan likewise hoped that HexaPro-based vaccines would reach more of the world– especially low- and middle-income nations, which so far have actually received just a portion of the total circulation of first-wave vaccines.” The share of the vaccines theyve gotten so far is dreadful,” Dr. McLellan said.To that end, the University of Texas set up a licensing plan for HexaPro that allows companies and laboratories in 80 low- and middle-income nations to utilize the protein in their vaccines without paying royalties.Meanwhile, Dr. Innes and his coworkers at PATH were looking for a method to increase the production of Covid-19 vaccines.